Curis
CRIS
#11244
Rank
C$2.03 M
Marketcap
C$0.84
Share price
9.39%
Change (1 day)
-59.84%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -C$12.48 Million

According to Curis's latest financial reports the company's current earnings are C$4.31 Million. In 2025 the company made an earning of -C$7.55 Million, an increase over its 2024 earnings that were of -C$59.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$12.48 Million65.42%
2025 -C$7.55 Million-87.38%
2024 -C$59.77 Million-5.77%
2023 -C$63.43 Million-13.1%
2022 -C$72.99 Million27.52%
2021 -C$57.24 Million65.09%
2020 -C$34.68 Million-9.1%
2019 -C$38.15 Million-4.73%
2018 -C$40.04 Million-41.95%
2017 -C$68.96 Million-14.37%
2016 -C$80.54 Million3.55%
2015 -C$77.77 Million271.52%
2014 -C$20.94 Million76.64%
2013 -C$11.86 Million
2011 -C$10.07 Million27.76%
2010 -C$7.88 Million-43.87%
2009 -C$14.04 Million-23.44%
2008 -C$18.34 Million56.66%
2007 -C$11.71 Million-16.71%
2006 -C$14.05 Million-36.92%
2005 -C$22.28 Million156.25%
2004 -C$8.7 Million-37.24%
2003 -C$13.86 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.65 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.64 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$86.47 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.44 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.46 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.11 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA